[HTML][HTML] Surgery for advanced non-small cell lung cancer patient after epidermal growth factor receptor tyrosine kinase inhibitor neoadjuvant therapy
Y Ning, M Bao, X Yan, D Xie, G Jiang - Annals of translational …, 2018 - ncbi.nlm.nih.gov
Background This study aimed to evaluate the survival of the advanced non-small cell lung
cancer (NSCLC) patients underwent salvage surgeries after EGFR-TKI neoadjuvant …
cancer (NSCLC) patients underwent salvage surgeries after EGFR-TKI neoadjuvant …
[引用][C] Surgery for advanced non-small cell lung cancer patient after epidermal growth factor receptor tyrosine kinase inhibitor neoadjuvant therapy
Y Ning, M Bao, X Yan, D Xie, G Jiang - Annals of Translational Medicine, 2018 - cir.nii.ac.jp
Surgery for advanced non-small cell lung cancer patient after epidermal growth factor receptor
tyrosine kinase inhibitor neoadjuvant therapy | CiNii Research CiNii 国立情報学研究所 学術 …
tyrosine kinase inhibitor neoadjuvant therapy | CiNii Research CiNii 国立情報学研究所 学術 …
Surgery for advanced non-small cell lung cancer patient after epidermal growth factor receptor tyrosine kinase inhibitor neoadjuvant therapy.
Y Ning, M Bao, X Yan, D Xie, G Jiang - Annals of Translational …, 2018 - europepmc.org
Background This study aimed to evaluate the survival of the advanced non-small cell lung
cancer (NSCLC) patients underwent salvage surgeries after EGFR-TKI neoadjuvant …
cancer (NSCLC) patients underwent salvage surgeries after EGFR-TKI neoadjuvant …
[PDF][PDF] Surgery for advanced non-small cell lung cancer patient after epidermal growth factor receptor tyrosine kinase inhibitor neoadjuvant therapy
Y Ning, M Bao, X Yan, D Xie, G Jiang - 2018 - cdn.amegroups.cn
Background: This study aimed to evaluate the survival of the advanced non-small cell lung
cancer (NSCLC) patients underwent salvage surgeries after EGFR-TKI neoadjuvant …
cancer (NSCLC) patients underwent salvage surgeries after EGFR-TKI neoadjuvant …
Surgery for advanced non-small cell lung cancer patient after epidermal growth factor receptor tyrosine kinase inhibitor neoadjuvant therapy
Y Ning, M Bao, X Yan, D Xie… - Annals of translational …, 2018 - pubmed.ncbi.nlm.nih.gov
Background This study aimed to evaluate the survival of the advanced non-small cell lung
cancer (NSCLC) patients underwent salvage surgeries after EGFR-TKI neoadjuvant …
cancer (NSCLC) patients underwent salvage surgeries after EGFR-TKI neoadjuvant …
[HTML][HTML] Surgery for advanced non-small cell lung cancer patient after epidermal growth factor receptor tyrosine kinase inhibitor neoadjuvant therapy
Y Ning, M Bao, X Yan, D Xie… - Annals of Translational …, 2018 - atm.amegroups.org
Background: This study aimed to evaluate the survival of the advanced non-small cell lung
cancer (NSCLC) patients underwent salvage surgeries after EGFR-TKI neoadjuvant …
cancer (NSCLC) patients underwent salvage surgeries after EGFR-TKI neoadjuvant …
Surgery for advanced non-small cell lung cancer patient after epidermal growth factor receptor tyrosine kinase inhibitor neoadjuvant therapy
Y Ning, M Bao, X Yan, D Xie… - Annals of Translational …, 2018 - atm.amegroups.org
Background: This study aimed to evaluate the survival of the advanced non-small cell lung
cancer (NSCLC) patients underwent salvage surgeries after EGFR-TKI neoadjuvant …
cancer (NSCLC) patients underwent salvage surgeries after EGFR-TKI neoadjuvant …